Correlation Between Vyne Therapeutics and Novartis
Can any of the company-specific risk be diversified away by investing in both Vyne Therapeutics and Novartis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vyne Therapeutics and Novartis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vyne Therapeutics and Novartis AG ADR, you can compare the effects of market volatilities on Vyne Therapeutics and Novartis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vyne Therapeutics with a short position of Novartis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vyne Therapeutics and Novartis.
Diversification Opportunities for Vyne Therapeutics and Novartis
-0.33 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Vyne and Novartis is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Vyne Therapeutics and Novartis AG ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novartis AG ADR and Vyne Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vyne Therapeutics are associated (or correlated) with Novartis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novartis AG ADR has no effect on the direction of Vyne Therapeutics i.e., Vyne Therapeutics and Novartis go up and down completely randomly.
Pair Corralation between Vyne Therapeutics and Novartis
Given the investment horizon of 90 days Vyne Therapeutics is expected to under-perform the Novartis. In addition to that, Vyne Therapeutics is 4.23 times more volatile than Novartis AG ADR. It trades about 0.0 of its total potential returns per unit of risk. Novartis AG ADR is currently generating about 0.04 per unit of volatility. If you would invest 10,304 in Novartis AG ADR on November 18, 2024 and sell it today you would earn a total of 239.00 from holding Novartis AG ADR or generate 2.32% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Vyne Therapeutics vs. Novartis AG ADR
Performance |
| Timeline |
| Vyne Therapeutics |
| Novartis AG ADR |
Vyne Therapeutics and Novartis Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vyne Therapeutics and Novartis
The main advantage of trading using opposite Vyne Therapeutics and Novartis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vyne Therapeutics position performs unexpectedly, Novartis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novartis will offset losses from the drop in Novartis' long position.| Vyne Therapeutics vs. Akari Therapeutics PLC | Vyne Therapeutics vs. Salarius Pharmaceuticals | Vyne Therapeutics vs. SAB Biotherapeutics | Vyne Therapeutics vs. GeoVax Labs |
| Novartis vs. AstraZeneca PLC ADR | Novartis vs. GlaxoSmithKline PLC ADR | Novartis vs. Roche Holding Ltd | Novartis vs. Bristol Myers Squibb |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |